Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Relugolix CT
Locations
1
United States
University of Michigan
Ann Arbor, Michigan, United States
Start Date
December 8, 2025
Primary Completion Date
August 1, 2028
Completion Date
September 1, 2028
Last Updated
February 18, 2026
NCT07472842
NCT06168058
NCT07471373
NCT05951452
NCT06611501
NCT06974773
Lead Sponsor
University of Michigan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions